Comparison of the prognosis of neoadjuvant chemoradiotherapy treatment with surgery alone in esophageal carcinoma: a meta-analysis
Hai-Feng Ma, Guo-Xiao Lv, Zhong-Fang Cai, Da-Hai Zhang Department of Radiotherapy, Dongyang People’s Hospital, Dongyang, Zhejiang, China Background: Resection remains the best treatment for carcinoma of the esophagus in terms of local control, but local recurrence and distant metastasis...
Main Authors: | Ma HF, Lv GX, Cai ZF, Zhang DH |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-06-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/comparison-of-the-prognosis-of-neoadjuvant-chemoradiotherapy-treatment-peer-reviewed-article-OTT |
Similar Items
-
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
by: Dan Aravot, et al.
Published: (2019-01-01) -
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
by: Hui‐Jiang Gao, et al.
Published: (2020-09-01) -
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma
by: Wenjie Ni, et al.
Published: (2020-02-01) -
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer
by: Nicola Simoni, et al.
Published: (2020-12-01) -
A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer
by: He-San Luo, et al.
Published: (2020-10-01)